Company / Operating Income per Share
Ovid Therapeutics Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.87
FY2025
5-year range
-$0.87 / $1.77
FY2022-FY2025
Trend
-3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has declined for 3 consecutive years, from $1.77 in FY2022 to $-0.87 in FY2025.
Based on SEC 10-K filings.
-0.87 in FY2025.
Declined from $-0.79 to $-0.87 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Ovid Therapeutics Inc.'s operating income per share has declined for 3 consecutive years.
- In FY2025, operating income per share decreased 3.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.87 | -3.9% |
| FY2024 | -$0.84 | -6.4% |
| FY2023 | -$0.79 | -144.7% |
| FY2022 | $1.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026